Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-04-13 @ 10:35 AM
Study NCT ID:
NCT01253668
Status:
TERMINATED
Last Update Posted:
2021-04-13
First Post:
2010-11-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Brivanib Metastatic Renal Cell Carcinoma
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
ACTUAL
Primary Completion Date:
2013-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-30
First Submit QC Date:
None
Study First Post Date:
2010-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-02-24
Results First Submit QC Date:
None
Results First Post Date:
2021-03-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-04-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-03-18
Last Update Post Date:
2021-04-13
Last Update Post Date Type:
ACTUAL